April 26, 2018 / 8:09 PM / 3 months ago

BRIEF-MorphoSys Announces Approval Of Tremfya(R)In South Korea

April 26 (Reuters) - MorphoSys AG:

* DGAP-NEWS: MORPHOSYS ANNOUNCES APPROVAL OF TREMFYA(R) (GUSELKUMAB) IN SOUTH KOREA

* MORPHOSYS IS ELIGIBLE TO RECEIVE ROYALTIES ON NET SALES OF TREMFYA

* AFFILIATE OF ITS LICENSEE, JANSSEN KOREA REPORTED THAT SOUTH KOREA’S MINISTRY OF FOOD AND DRUG SAFETY HAS APPROVED TREMFYA Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below